JavaScript is disabled for your browser. Some features of this site may not work without it.
CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab
Title:CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab; ravtansine in combination with ramucirumab in pretreated patients with; gastric or gastroesophageal junction adenocarcinoma (GA/GEJA)
Esposito, FM; Lee, J; Rha, SY; Penkov, KD; Moisseev, A; Van den Eynde, M; Prenen, H; Garcia, MD; Gumus, M; Sagawa, T; Nechaeva, M; Kajiwara, T; Harputluoglu, H; Charbonnier, L; Bensfia, S; Yang, N; Oh, DY